Larvol Delta - Afmed-Announces-Positive-Early-Efcacy-and-Progression-Free-Survival-Results-of-AFM24102-Study-in-EGFR-WildType-NonSmall-Cell-Lung-Cancer-at-the-Annual-Meeting-of-the-American-Society-of-Clinical-Oncology-2024

AFM24 - Affimed

https://www.globenewswire.com/news-release/2024/05/23/2887697/0/en/Affimed-Announces-Positive-Early-Efficacy-and-Progression-Free-Survival-Results-of-AFM24-102-Study-in-EGFR-Wild-Type-Non-Small-Cell-Lung-Cancer-at-the-Annual-Meeting-of-the-America.html

May 23, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next